Top pharmaceutical company evaluates Optimer for precision liver medicine
Aptamer Group plc, the developer of novel Optimer® binders to enable innovation in the life sciences industry, today announces that its Optimer binder against cells associated with fibrotic liver disease, developed for targeted delivery of therapeutic …